|
|
| Your Trusted Biologics Testing Partner | SGS Supports biopharmaceutical clients from discovery to clinical development and commercialization, through a comprehensive scope of expert-led quality control testing for raw materials, APIs, and finished products. Whether you need testing support through every stage of the drug development cycle or just when your in-house capabilities are limited, SGS serves as your trusted partner to support product characterization, method development and validation, bioanalysis and final GMP product release. Learn more. |
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | In this part two, James Doherty, President and Chief Development Officer, provides readers with a window into the contracting strategy of Acumen Pharmaceuticals, a biotech developing a novel therapeutic for the treatment of Alzheimer’s disease (AD). Acumen has announced it entered a CDMO contract for both clinical and any future commercial supply. |
|
|
|
If The CDMO Shoe Fits, Wear It Now | By Louis Garguilo, chief editor, Outsourced Pharma | Acumen Pharmaceuticals, a clinical-stage biopharmaceutical developing a novel therapeutic for the treatment of Alzheimer’s, selected its manufacturing partner early on, and told the world about it. Chief Editor Louis Garguilo asked the chief development officer about that strategy. |
|
|
|
|
Gene-Edited CAR T Cells For Off-The-Shelf Cancer Therapy | Poster | Precision NanoSystems | We report on the use of a novel lipid nanoparticle (LNP) reagent in a validated protocol to achieve successful complex gene editing in primary T cells with high efficiency while maintaining high cell viability. |
|
|
|
|
|
|
Accelerating Treg Therapy Manufacturing | Case Study | ElevateBio | The integrity of your master cell bank (MCB) is crucial for advanced therapy production. Choosing a provider with specialized expertise, top-tier storage, and precise record-keeping is essential. |
|
|
Meet An Optimized Suspension-Based Platform Technology | Application Note | By Lisa Prendergast and Bingnan Gu, Lonza | Discover a ready-to-use, suspension-based platform technology for transient transfection of LVVs that eliminates the need to transition from small-scale adherent processes. |
|
|
|
|
|
| Partner Week is back this October! From 10/21 through 10/25, hear from CDMOs across Fill/Finish, Large Molecule, Small Molecule, Cell & Gene, and our newest addition: ADC. Bring your questions and requirements, skip the small talk, and get right down to the business of finding the best-fit partner for your short- and longer-term drug development needs. Register for free at this link. |
|
|
|
Codex HiCap RNA Polymerase | Aldevron | This revolutionary enzyme delivers enhanced safety, cost-effectiveness, and performance, empowering researchers to unlock the full potential of mRNA therapeutics. |
|
|
|
Genomics Experience In Oncology | Cerba Research | Discover comprehensive genomics solutions to advance your clinical trials, with tailored support from expert teams, state-of-the-art technologies, and a focus on oncology and beyond. |
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
Connect With Outsourced Pharma: |
|
|
|